These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21881098)

  • 1. Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study.
    Haro JM; Novick D; Bertsch J; Karagianis J; Dossenbach M; Jones PB
    Br J Psychiatry; 2011 Sep; 199(3):194-201. PubMed ID: 21881098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in treatment response and three year course of schizophrenia across the world.
    Novick D; Haro JM; Hong J; Brugnoli R; Lepine JP; Bertsch J; Karagianis J; Dossenbach M; Alvarez E
    J Psychiatr Res; 2012 Jul; 46(7):856-64. PubMed ID: 22575332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.
    Karagianis J; Novick D; Pecenak J; Haro JM; Dossenbach M; Treuer T; Montgomery W; Walton R; Lowry AJ
    Int J Clin Pract; 2009 Nov; 63(11):1578-88. PubMed ID: 19780867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
    Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
    Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the course of schizophrenia across diverse regions of the world.
    Novick D; Montgomery W; Treuer T; Moneta MV; Haro JM
    Neuropsychiatr Dis Treat; 2016; 12():2927-2939. PubMed ID: 27881918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
    Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M;
    J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.
    Knapp M; Windmeijer F; Brown J; Kontodimas S; Tzivelekis S; Haro JM; Ratcliffe M; Hong J; Novick D;
    Pharmacoeconomics; 2008; 26(4):341-58. PubMed ID: 18370568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.
    Haro JM; Edgell ET; Jones PB; Alonso J; Gavart S; Gregor KJ; Wright P; Knapp M;
    Acta Psychiatr Scand; 2003 Mar; 107(3):222-32. PubMed ID: 12580830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
    Novick D; Haro JM; Suarez D; Vieta E; Naber D
    Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.
    Kasper S; Lowry AJ; Hodge A; Bitter I; Dossenbach M
    Schizophr Res; 2006 Jan; 81(2-3):139-43. PubMed ID: 16253478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics].
    Gasquet I; Chartier F; Tcherny-Lessenot S; Lépine JP
    Rev Epidemiol Sante Publique; 2009 Feb; 57(1):25-32. PubMed ID: 19162420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
    Gasquet I; Haro JM; Novick D; Edgell ET; Kennedy L; Lepine JP;
    Int Clin Psychopharmacol; 2005 Jul; 20(4):199-205. PubMed ID: 15933480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial.
    Fleischhacker WW; Kane JM; Geier J; Karayal O; Kolluri S; Eng SM; Reynolds RF; Strom BL
    J Clin Psychiatry; 2014 Mar; 75(3):e184-90. PubMed ID: 24717389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission in the outpatient care of schizophrenia: 3-year results from the Schizophrenia Outpatients Health Outcomes (SOHO) study in France.
    Gasquet I; Haro JM; Tcherny-Lessenot S; Chartier F; Lépine JP
    Eur Psychiatry; 2008 Oct; 23(7):491-6. PubMed ID: 18573640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain.
    Ciudad A; Haro JM; Alonso J; Bousoño M; Suárez D; Novick D; Gilaberte I
    Eur Psychiatry; 2008 Jan; 23(1):1-7. PubMed ID: 18023154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The European schizophrenia outpatient health outcomes (SOHO) study: baseline findings of the Spanish sample].
    Ciudad A; Prieto L; Olivares JM; Montejo AL; Ros S; Novick D;
    Actas Esp Psiquiatr; 2004; 32(4):227-35. PubMed ID: 15232752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS and Disability Progression in Latin America, Africa, Asia and the Middle East: A Systematic Review.
    Bonomi S; Jin S; Culpepper WJ; Wallin MT
    Mult Scler Relat Disord; 2021 Jun; 51():102885. PubMed ID: 33773273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
    Bertrand X; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):124-37. PubMed ID: 22154196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and number of children living in institutional care: global, regional, and country estimates.
    Desmond C; Watt K; Saha A; Huang J; Lu C
    Lancet Child Adolesc Health; 2020 May; 4(5):370-377. PubMed ID: 32151317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.